Skip to main content
Log in

Cigarette Smoking and Diffuse Lung Disease

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Cigarette smoke, a toxic collection of more than 4000 chemicals generated from combustion of tobacco plant leaves, is known to cause several respiratory ailments, including chronic bronchitis, emphysema and lung cancer, and is associated with an increase in respiratory infections. In addition, cigarette smoking is considered a principal aetiological factor responsible for the development of certain diffuse interstitial and bronchiolar lung diseases, namely respiratory bronchiolitis-interstitial lung disease (RB-ILD), desquamative interstitial pneumonia (DIP) and adult pulmonary Langerhans’ cell histiocytosis (PLCH). Although not exclusively seen in cigarette smokers, substantial clinical and epidemiological data support a central role for smoking as the primary causative agent of most RB-ILD, DIP and PLCH. Additional evidence in support of cigarette smoke as a primary aetiological agent in RB-ILD, DIP and PLCH is the observation that smoking cessation may lead to disease improvement, while recurrence of these disorders has been observed to occur in the transplanted lung upon re-exposure to tobacco smoke. Furthermore, histopathological changes of respiratory bronchiolitis, DIP and PLCH (with or without co-existent emphysema) may be found on lung biopsy in the same individual, implicating smoking as a common inciting agent of these diverse lesions. Recent studies also suggest a role for cigarette smoking as a potential co-factor in the development of acute eosinophilic pneumonia, usual interstitial pneumonia and rheumatoid arthritis-associated interstitial lung disease. In the current review, we propose a novel classification that takes into account the complex relationship between cigarette smoking and diffuse lung diseases. Investigation on the role of smoking as a potential causative factor or modifier of these diverse diffuse lung diseases is important, as smoking cessation utilizing state-of-the-art tobacco cessation efforts should be a central part of therapy, while pharmacotherapy with corticosteroids or other immune modifying agents should be reserved for selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References|

  1. Fraig M, Shreesha U, Savici D, et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002 May; 26(5): 647–53

    Article  PubMed  Google Scholar 

  2. Friedman PJ, Liebow AA, Sokoloff J. Eosinophilic granuloma of lung: clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore) 1981 Nov; 60(6): 385–96

    Article  CAS  Google Scholar 

  3. Moon J, du Bois RM, Colby TV, et al. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999 Nov; 54(11): 1009–14

    Article  PubMed  CAS  Google Scholar 

  4. Myers JL, Veal Jr CF, Shin MS, et al. Respiratory bronchiolitis causing interstitial lung disease: a clinicopathologic study of six cases. Am Rev Respir Dis 1987 Apr; 135(4): 880–4

    PubMed  CAS  Google Scholar 

  5. Ryu JH, Myers JL, Capizzi SA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005 Jan; 127(1): 178–84

    Article  PubMed  Google Scholar 

  6. Vassallo R, Ryu JH, Schroeder DR, et al. Clinical outcomes of pulmonary Langerhans’ cell histiocytosis in adults. N Engl J Med 2002 Feb 14; 346(7): 484–90

    Article  PubMed  Google Scholar 

  7. Caminati A, Harari S. Smoking-related interstitial pneumonias and pulmonary Langerhans cell histiocytosis. Proc Am Thorac Soc 2006 Jun; 3(4): 299–306

    Article  PubMed  Google Scholar 

  8. Miyake Y, Sasaki S, Yokoyama T, et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann Occup Hyg 2005 Apr; 49(3): 259–65

    Article  PubMed  Google Scholar 

  9. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155(1): 242–8

    PubMed  CAS  Google Scholar 

  10. Nakajima M, Matsushima T. Acute eosinophilic pneumonia following cigarette smoking. Intern Med 2000 Oct; 39(10): 759–60

    Article  PubMed  CAS  Google Scholar 

  11. Watanabe K, Fujimura M, Kasahara K, et al. Acute eosinophilic pneumonia following cigarette smoking: a case report including cigarette-smoking challenge test. Intern Med 2002 Nov; 41(11): 1016–20

    Article  PubMed  Google Scholar 

  12. Kitahara Y, Matsumoto K, Taooka Y, et al. Cigarette smokinginduced acute eosinophilic pneumonia showing tolerance in broncho-alveolar lavage findings. Intern Med 2003 Oct; 42(10): 1016–21

    Article  PubMed  Google Scholar 

  13. Shorr AF, Scoville SL, Cersovsky SB, et al. Acute eosinophilic pneumonia among US Military personnel deployed in or near Iraq. JAMA 2004; 292(24): 2997–3005

    Article  PubMed  CAS  Google Scholar 

  14. Girard M, Israel-Assayag E, Cormier Y. Pathogenesis of hypersensitivity pneumonitis. Curr Opin Allergy Clin Immunol 2004 Apr; 4(2): 93–8

    Article  PubMed  Google Scholar 

  15. Vassallo R, Jensen EA, Colby TV, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003 Oct; 124(4): 1199–205

    Article  PubMed  Google Scholar 

  16. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol 1993 Oct; 17(10): 971–86

    Article  PubMed  CAS  Google Scholar 

  17. Shiota Y, Kawai T, Matsumoto H, et al. Acute eosinophilic pneumonia following cigarette smoking. Intern Med 2000 Oct; 39(10): 830–3

    Article  PubMed  CAS  Google Scholar 

  18. Al-Saieg N, Moammar O, Kartan R. Flavored cigar smoking induces acute eosinophilic pneumonia. Chest 2007 Apr; 131(4): 1234–7

    Article  PubMed  Google Scholar 

  19. Miki K, Miki M, Okano Y, et al. Cigarette smoke-induced acute eosinophilic pneumonia accompanied with neutrophilia in the blood. Intern Med 2002 Nov; 41(11): 993–6

    Article  PubMed  Google Scholar 

  20. Donaghy M, Rees AJ. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 1983 Dec 17; II(8364): 1390–3

    Article  Google Scholar 

  21. Saag KG, Kolluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease: determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996 Oct; 39(10): 1711–9

    Article  PubMed  CAS  Google Scholar 

  22. Wolfe F. The effect of smoking on clinical, laboratory, and radiographie status in rheumatoid arthritis. J Rheumatol 2000 Mar; 27(3): 630–7

    PubMed  CAS  Google Scholar 

  23. Peros-Golubicic T, Ljubic S. Cigarette smoking and sarcoidosis. Acta Med Croatica 1995; 49(4-5): 187–93

    PubMed  CAS  Google Scholar 

  24. Israel-Assayag E, Dakhama A, Lavigne S, et al. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999 Jun; 159(6): 1830–4

    PubMed  CAS  Google Scholar 

  25. Colby TV, Lombard C. Histiocytosis X in the lung. Human Pathol 1983 Oct; 14(10): 847–56

    Article  CAS  Google Scholar 

  26. Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989 Nov; 64(11): 1373–80

    Article  PubMed  CAS  Google Scholar 

  27. Delobbe A, Durieu J, Duhamel A, et al. Determinants of survival in pulmonary Langerhans’ cell granulomatosis (histiocytosis X). Groupe d’Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 1996 Oct; 9(10): 2002–6

    Article  PubMed  CAS  Google Scholar 

  28. Craig PJ, Wells AU, Doffman S, et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004 Sep; 45(3): 275–82

    Article  PubMed  CAS  Google Scholar 

  29. Nakajima M, Manabe T, Niki Y, et al. A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance. Chest 2000 Nov; 118(5): 1517–8

    Article  PubMed  CAS  Google Scholar 

  30. Luukkainen R, Saltyshev M, Pakkasela R, et al. Relationship of rheumatoid factor to lung diffusion capacity in smoking and non-smoking patients with rheumatoid arthritis. Scand Rheumatol 1995; 24(2): 119–20

    Article  CAS  Google Scholar 

  31. Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988 Jul; 43(7): 516–24

    Article  PubMed  CAS  Google Scholar 

  32. Hance AJ, Basset F, Saumon G, et al. Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 1986; 465: 643–56

    Article  PubMed  CAS  Google Scholar 

  33. Warren CP. Extrinsic allergic alveolitis: a disease commoner in non-smokers. Thorax 1977 Oct; 32(5): 567–9

    Article  PubMed  CAS  Google Scholar 

  34. Douglas JG, Middleton WG, Gaddie J, et al. Sarcoidosis: a disorder commoner in non-smokers? Thorax 1986 Oct; 41(10): 787–91

    Article  PubMed  CAS  Google Scholar 

  35. Etienne B, Bertocchi M, Gamondes JP, et al. Relapsing pulmonary Langerhans cell histiocytosis after lung transplantation. Am J Respir Crit Care Med 1998 Jan; 157(1): 288–91

    PubMed  CAS  Google Scholar 

  36. Mogulkoc N, Veral A, Bishop PW, et al. Pulmonary Langerhans’ cell histiocytosis: radiologie resolution following smoking cessation. Chest 1999 May; 115(5): 1452–5

    Article  PubMed  CAS  Google Scholar 

  37. Portnoy J, Veraldi KL, Schwarz MI, et al. Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest 2007 Mar; 131(3): 664–71

    Article  PubMed  Google Scholar 

  38. Abbott GF, Rosado-de-Christenson ML, Franks TJ, et al. From the archives of the AFIP: pulmonary Langerhans cell histiocytosis. Radiographies 2004 May–Jun; 24(3): 821–41

    Article  Google Scholar 

  39. Dauriat G, Mal H, Thabut G, et al. Lung transplantation for pulmonary Langerhans’ cell histiocytosis: a multicenter analysis. Transplantation 2006 Mar 15; 81(5): 746–50

    Article  PubMed  Google Scholar 

  40. Bernstrand C, Cederlund K, Ashtrom L, et al. Smoking preceded pulmonary involvement in adults with Langerhans cell histiocytosis diagnosed in childhood. Acta Paediatr 2000 Nov; 89(11): 1389–92

    Article  PubMed  CAS  Google Scholar 

  41. Zeid NA, Muller HK. Tobacco smoke induced lung granulomas and tumors: association with pulmonary Langerhans cells. Pathology 1995 Jul; 27(3): 247–54

    Article  PubMed  CAS  Google Scholar 

  42. Alp H, Daum RS, Abrahams C, et al. Acute eosinophilic pneumonia: a cause of reversible, severe, noninfectious respiratory failure. J Pediatr 1998 Mar; 132 (3 Pt 1): 540–3

    Article  PubMed  CAS  Google Scholar 

  43. Nakagome K, Kato J, Kubota S, et al. Acute eosinophilic pneumonia induced by cigarette smoking [in Japanese]. Nihon Kokyuki Gakkai Zasshi 2000 Feb; 38(2): 113–6

    PubMed  CAS  Google Scholar 

  44. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLADR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006 Jan; 54(1): 38–46

    Article  PubMed  CAS  Google Scholar 

  45. Vassallo R, Tamada K, Lau JS, et al. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005 Aug 15; 175(4): 2684–91

    PubMed  CAS  Google Scholar 

  46. Cormier Y, Belanger J, Durand P. Factors influencing the development of serum precipitins to farmer’s lung antigen in Quebec dairy farmers. Thorax 1985 Feb; 40(2): 138–42

    Article  PubMed  CAS  Google Scholar 

  47. Hakala M, Paakko P, Huhti E, et al. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 1990 Dec; 9(4): 452–60

    Article  PubMed  CAS  Google Scholar 

  48. Churg A, Muller NL, Flint J, et al. Chronic hypersensitivity pneumonitis. Am J Surg Pathol 2006 Feb; 30(2): 201–8

    Article  PubMed  Google Scholar 

  49. Ranney L, Melvin C, Lux L, et al. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med 2006 Dec 5; 145(11): 845–56

    PubMed  Google Scholar 

  50. Lancaster T, Stead L, Silagy C, et al. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000 Aug 5; 321(7257): 355–8

    Article  PubMed  CAS  Google Scholar 

  51. Molyneux A. Nicotine replacement therapy. BMJ 2004 Feb 21; 328(7437): 454–6

    Article  PubMed  Google Scholar 

  52. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; (3): CD000146

  53. Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997 Oct 23; 337(17): 1195–202

    Article  PubMed  CAS  Google Scholar 

  54. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006 Jul 5; 296(1): 56–63

    Article  PubMed  CAS  Google Scholar 

  55. Kuschner WG, D’Alessandro A, Wong H, et al. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996 Oct; 9(10): 1989–94

    Article  PubMed  CAS  Google Scholar 

  56. Casolaro MA, Bernaudin JF, Saltini C, et al. Accumulation of Langerhans’ cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Am Rev Respir Dis 1988 Feb; 137(2): 406–11

    PubMed  CAS  Google Scholar 

  57. Remy-Jardin M, Remy J, Gosselin B, et al. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993 Mar; 186(3): 643–51

    PubMed  CAS  Google Scholar 

  58. Tomita K, Caramori G, Lim S, et al. Increased p21(CIPl/ WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med 2002 Sep 1; 166(5): 724–31

    Article  PubMed  Google Scholar 

  59. Tazi A, Bonay M, Bergeron A, et al. Role of granulocytemacrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Thorax 1996 Jun; 51(6): 611–4

    Article  PubMed  CAS  Google Scholar 

  60. Tazi A, Bouchonnet F, Grandsaigne M, et al. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/ Langerhans cells in human lung and lung cancers. J Clin Invest 1993 Feb; 91(2): 566–76

    Article  PubMed  CAS  Google Scholar 

  61. Wang RD, Wright JL, Churg A. Transforming growth factorbetal drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005 Oct; 33(4): 387–93

    Article  PubMed  CAS  Google Scholar 

  62. D’Hulst AI, Vermaelen KY, Brusselle GG, et al. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005 Aug; 26(2): 204–13

    Article  PubMed  CAS  Google Scholar 

  63. Lu LM, Zavitz CC, Chen B, et al. Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol 2007 Jan 15; 178(2): 936–43

    PubMed  CAS  Google Scholar 

  64. Kode A, Yang SR, Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 2006; 7: 132

    Article  PubMed  CAS  Google Scholar 

  65. Yang SR, Chida AS, Bauter MR, et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol 2006 Jul; 291(1): L46–57

    CAS  Google Scholar 

  66. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974 Oct 10; 291(15): 755–8

    Article  PubMed  CAS  Google Scholar 

  67. Ryu JH, Colby TV, Hartman TE, et al. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001 Jan; 17(1): 122–32

    Article  PubMed  CAS  Google Scholar 

  68. Mavridou D, Laws D. Respiratory bronchiolitis associated interstitial lung disease (RB-ILD): a case of an acute presentation. Thorax 2004 Oct; 59(10): 910–1

    Article  PubMed  CAS  Google Scholar 

  69. Hartman TE, Tazelaar HD, Swensen SJ, et al. Cigarette smoking: CT and pathologic findings of associated pulmonary diseases. Radiographics 1997 Mar–Apr; 17(2): 377–90

    PubMed  CAS  Google Scholar 

  70. Aubry MC, Wright JL, Myers JL. The pathology of smokingrelated lung diseases. Clin Chest Med 2000 Mar; 21(1): 11–35,vii

    Article  PubMed  CAS  Google Scholar 

  71. Wells AU, Nicholson AG, Hansell DM, et al. Respiratory bronchiolitis-associated interstitial lung disease. Semin Respir Crit Care Med 2003 Oct; 24(5): 585–94

    Article  PubMed  Google Scholar 

  72. Liebow AA, Steer A, Billingsley JG. Desquamative interstitial pneumonia. Am J Med 1965 Sep; 39: 369–404

    Article  PubMed  CAS  Google Scholar 

  73. Iskandar SB, McKinney LA, Shah L, et al. Desquamative interstitial pneumonia and hepatitis C virus infection: a rare association. South Med J 2004 Sep; 97(9): 890–3

    Article  PubMed  Google Scholar 

  74. Flores-Franco RA, Luevano-Flores E, Gaston-Ramirez C. Sirolimus-associated desquamative interstitial pneumonia. Respiration 2007; 74(2): 237–8

    Article  PubMed  Google Scholar 

  75. Hansell DM, Nicholson AG. Smoking-related diffuse parenchymal lung disease: HRCT-pathologic correlation. Semin Respir Crit Care Med 2003 Aug; 24(4): 377–92

    Article  PubMed  Google Scholar 

  76. Heyneman LE, Ward S, Lynch DA, et al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? Am J Roentgenol 1999 Dec; 173(6): 1617–22

    CAS  Google Scholar 

  77. Mueller-Mang C, Grosse C, Schmid K, et al. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics 2007 May–Jun; 27(3): 595–615

    Article  PubMed  Google Scholar 

  78. Nagai S, Hoshino Y, Hayashi M, et al. Smoking-related interstitial lung diseases. Curr Opin Pulm Med 2000 Sep; 6(5): 415–9

    Article  PubMed  CAS  Google Scholar 

  79. Matsuo K, Tada S, Kataoka M, et al. Spontaneous remission of desquamative interstitial pneumonia. Intern Med 1997 Oct; 36(10): 728–31

    Article  PubMed  CAS  Google Scholar 

  80. Patchefsky AS, Fraimow W, Hoch WS. Desquamative interstitial pneumonia. Pathological findings and follow-up in 13 patients. Arch Intern Med 1973 Aug; 132(2): 222–5

    Article  PubMed  CAS  Google Scholar 

  81. Flusser G, Gurman G, Zirkin H, et al. Desquamative interstitial pneumonitis causing acute respiratory failure, responsive only to immunosuppressants. Respiration 1991; 58(5-6): 324–6

    Article  PubMed  CAS  Google Scholar 

  82. Verleden GM, Sels F, Van Raemdonck D, et al. Possible recurrence of desquamative interstitial pneumonitis in a single lung transplant recipient. Eur Respir J 1998 Apr; 11(4): 971–4

    Article  PubMed  CAS  Google Scholar 

  83. Vassallo R, Ryu JH, Colby TV, et al. Pulmonary Langerhans’ cell histiocytosis. N Engl J Med 2000 Jun 29; 342(26): 1969–78

    Article  PubMed  CAS  Google Scholar 

  84. Tazi A. Adult pulmonary Langerhans’ cell histiocytosis. Eur Respir J 2006 Jun; 27(6): 1272–85

    Article  PubMed  CAS  Google Scholar 

  85. Yousem SA, Colby TV, Chen YY, et al. Pulmonary Langerhans’ cell histiocytosis: molecular analysis of clonality. Am J Surg Pathol 2001 May; 25(5): 630–6

    Article  PubMed  CAS  Google Scholar 

  86. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/ Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol 1997 Sep; 29(3): 157–66

    Article  PubMed  CAS  Google Scholar 

  87. Vassallo R, Ryu JH. Pulmonary Langerhans’ cell histiocytosis. Clin Chest Med 2004 Sep; 25(3): 561–71, vii

    Article  PubMed  Google Scholar 

  88. Arnett NL, Schulz DM. Primary pulmonary eosinophilic granuloma. Radiology 1957 Aug; 69(2): 224–30

    PubMed  CAS  Google Scholar 

  89. Lewis JG. Eosinophilic granuloma and its variants with special reference to lung involvement, a report of 12 patients. Q J Med 1964 Jul; 33: 337–59

    PubMed  CAS  Google Scholar 

  90. Lewis JG. Pulmonary manifestations of histiocytosis X. Proc R Soc Med 1971 Apr; 64(4): 338–40

    PubMed  CAS  Google Scholar 

  91. Smith M, McCormack LJ, Van Ordstrand HS, et al. “Primary” pulmonary histiocytosis X. Chest 1974 Feb; 65(2): 176–80

    Article  PubMed  CAS  Google Scholar 

  92. Chaowalit N, Pellikka PA, Decker PA, et al. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc 2004; 79(10): 1269–75

    Article  PubMed  Google Scholar 

  93. Aguayo SM, King Jr TE, Waldron Jr JA, et al. Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest 1990 Sep; 86(3): 838–44

    Article  PubMed  CAS  Google Scholar 

  94. Asakura S, Colby TV, Limper AH. Tissue localization of transforming growth factor-betal in pulmonary eosinophilic granuloma. Am J Respir Crit Care Med 1996 Nov; 154(5): 1525–30

    PubMed  CAS  Google Scholar 

  95. Mendez JL, Nadrous HF, Vassallo R, et al. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest 2004 Mar; 125(3): 1028–32

    Article  PubMed  Google Scholar 

  96. Crausman RS, Jennings CA, Tuder RM, et al. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med 1996 Jan; 153(1): 426–35

    PubMed  CAS  Google Scholar 

  97. Moore AD, Godwin JD, Muller NL, et al. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 1989 Jul; 172(1): 249–54

    PubMed  CAS  Google Scholar 

  98. Brauner MW, Grenier P, Mouelhi MM, et al. Pulmonary histiocytosis X: evaluation with high-resolution CT. Radiology 1989 Jul; 172(1): 255–8

    PubMed  CAS  Google Scholar 

  99. Brauner MW, Grenier P, Tijani K, et al. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 1997 Aug; 204(2): 497–502

    PubMed  CAS  Google Scholar 

  100. Soler P, Chollet S, Jacque C, et al. Immunocytochemical characterization of pulmonary histiocytosis X cells in lung biopsies. Am J Pathol 1985 Mar; 118(3): 439–51

    PubMed  CAS  Google Scholar 

  101. Chollet S, Soler P, Bernaudin JF, et al. Exploratory bronchoalveolar lavage [in French]. Presse Med 1984 Jun 9; 13(24): 1503–8

    PubMed  CAS  Google Scholar 

  102. Chollet S, Soler P, Dournovo P, et al. Diagnosis of pulmonary histiocytosis X by immunodetection of Langerhans cells in bronchoalveolar lavage fluid. Am J Pathol 1984 May; 115(2): 225–32

    PubMed  CAS  Google Scholar 

  103. Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000 Jan; 161(1): 216–23

    PubMed  CAS  Google Scholar 

  104. Negrin-Dastis S, Butenda D, Dorzee J, et al. Complete disappearance of lung abnormalities on high-resolution computed tomography: a case of histiocytosis X. Can Respir J 2007 May–Jun; 14(4): 235–7

    PubMed  Google Scholar 

  105. Aerni MR, Aubry MC, Myers JL, et al. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Respir Med 2008 Feb; 102(2): 316–9

    Article  PubMed  Google Scholar 

  106. Pardanani A, Phyliky RL, Li CY, et al. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Mayo Clin Proc 2003 Mar; 78(3): 301–6

    Article  PubMed  CAS  Google Scholar 

  107. Saleem I, Moss J, Egan JJ. Lung transplantation for rare pulmonary diseases. Sarcoidosis Vasc Diffuse Lung Dis 2005 Dec; 22 Suppl. 1: S85–90

    PubMed  Google Scholar 

  108. Yokoyama A, Mizushima Y, Suzuki H, et al. Acute eosinophilic pneumonia induced by minocycline: prominent Kerley B lines as a feature of positive re-challenge test. Jpn J Med 1990 Mar–Apr; 29(2): 195–8

    Article  PubMed  CAS  Google Scholar 

  109. Barnes MT, Bascunana J, Garcia B, et al. Acute eosinophilic pneumonia associated with antidepressant agents. Pharm World Sci 1999 Oct; 21(5): 241–2

    Article  PubMed  CAS  Google Scholar 

  110. Noh H, Lee YK, Kan SW, et al. Acute eosinophilic pneumonia associated with amitriptyline in a hemodialysis patient. Yonsei Med J 2001 Jun; 42(3): 357–9

    PubMed  CAS  Google Scholar 

  111. McCormick M, Nelson T. Cocaine-induced fatal acute eosinophilic pneumonia: a case report. WMJ 2007 Apr; 106(2): 92–5

    PubMed  Google Scholar 

  112. Rom WN, Weiden M, Garcia R, et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 2002 Sep 15; 166(6): 797–800

    Article  PubMed  Google Scholar 

  113. Takizawa H. Acute eosinophilic pneumonia: possible role of hyperreactivity of airway epithelial cells. Intern Med 2002 Nov; 41(11): 917

    Article  PubMed  Google Scholar 

  114. Glazer CS, Cohen LB, Schwarz MI. Acute eosinophilic pneumonia in AIDS. Chest 2001 Nov; 120(5): 1732–5

    Article  PubMed  CAS  Google Scholar 

  115. Hirai K, Yamazaki Y, Okada K, et al. Acute eosinophilic pneumonia associated with smoke from fireworks. Intern Med 2000 May; 39(5): 401–3

    Article  PubMed  CAS  Google Scholar 

  116. Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000 Sep; 216(3): 773–80

    PubMed  CAS  Google Scholar 

  117. Allen J. Acute eosinophilic pneumonia. Semin Respir Crit Care Med 2006 Apr; 27(2): 142–7

    Article  PubMed  Google Scholar 

  118. Fujimura M, Yasui M, Shinagawa S, et al. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug-induced eosinophilic pneumonia. Respir Med 1998 May; 92(5): 743–9

    Article  PubMed  CAS  Google Scholar 

  119. Oshikawa K, Kuroiwa K, Tokunaga T, et al. Acute eosinophilic pneumonia with increased soluble ST2 in serum and bronchoalveolar lavage fluid. Respir Med 2001 Jun; 95(6): 532–3

    Article  PubMed  CAS  Google Scholar 

  120. Daimon T, Tajima S, Oshikawa K, et al. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia. Intern Med 2005 Aug; 44(8): 811–7

    Article  PubMed  Google Scholar 

  121. Jeong YJ, Kim KI, Seo IJ, et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics 2007 May–Jun; 27(3): 617–37

    Article  PubMed  Google Scholar 

  122. Ricker DH, Taylor SR, Gartner Jr JC, et al. Fatal pulmonary aspergillosis presenting as acute eosinophilic pneumonia in a previously healthy child. Chest 1991 Sep; 100(3): 875–7

    Article  PubMed  CAS  Google Scholar 

  123. Buddharaju VL, Saraceno JL, Rosen JM, et al. Acute eosinophilic pneumonia associated with shock. Crit Care Med 1999 Sep; 27(9): 2014–6

    Article  PubMed  CAS  Google Scholar 

  124. Philit F, Etienne-Mastroianni B, Parrot A, et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am J Respir Crit Care Med 2002 Nov 1; 166(9): 1235–9

    Article  PubMed  Google Scholar 

  125. Benz K, Amann K, Dittrich K, et al. Patient with antibodynegative relapse of Goodpasture syndrome. Clin Nephrol 2007 Apr; 67(4): 240–4

    PubMed  CAS  Google Scholar 

  126. Flaherty KR, Martinez FJ. Cigarette smoking in interstitial lung disease: concepts for the internist. Med Clin North Am 2004 Nov; 88(6): 1643–53, xiii

    Article  PubMed  Google Scholar 

  127. King Jr TE, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164(7): 1171–81

    PubMed  Google Scholar 

  128. Antoniou KM, Hansell DM, Rubens MB, et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008 Jan 15; 177(2): 190–4

    Article  PubMed  Google Scholar 

  129. Arima K, Ando M, Ito K, et al. Effect of cigarette smoking on prevalence of summer-type hypersensitivity pneumonitis caused by Trichosporon cutaneum. Arch Environ Health 1992 Jul–Aug; 47(4): 274–8

    Article  PubMed  CAS  Google Scholar 

  130. Depierre A, Dalphin JC, Pernet D, et al. Epidemiological study of farmer’s lung in five districts of the French Doubs province. Thorax 1988 Jun; 43(6): 429–35

    Article  PubMed  CAS  Google Scholar 

  131. Chang JC, Distler SG, Kaplan AM. Tobacco smoke suppresses T cells but not antigen-presenting cells in the lung-associated lymph nodes. Toxicol Appl Pharmacol1990 Mar 1; 102(3): 514–23

    Article  PubMed  CAS  Google Scholar 

  132. Ohtsuka Y, Munakata M, Tanimura K, et al. Smoking promotes insidious and chronic farmer’s lung disease, and deteriorates the clinical outcome. Intern Med 1995 Oct; 34(10): 966–71

    Article  PubMed  CAS  Google Scholar 

  133. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004 Dec 15; 170(12): 1324–30

    Article  PubMed  Google Scholar 

  134. Coates R, Neville E. The development of airways obstruction in sarcoidosis among smokers and non-smokers. Sarcoidosis 1993 Sep; 10(2): 115–7

    PubMed  CAS  Google Scholar 

  135. den Boon S, van Lill SW, Borgdorff MW, et al. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax 2005 Jul; 60(7): 555–7

    Article  Google Scholar 

  136. Ariyothai N, Podhipak A, Akarasewi P, et al. Cigarette smoking and its relation to pulmonary tuberculosis in adults. Southeast Asian J Trop Med Public Health 2004 Mar; 35(1): 219–27

    PubMed  Google Scholar 

  137. Kolappan C, Gopi PG. Tobacco smoking and pulmonary tuberculosis. Thorax 2002 Nov; 57(11): 964–6

    Article  PubMed  CAS  Google Scholar 

  138. Guidon G, BoisclairD. Past, current and future trends in tobacco use. Health nutrition and population discussion paper, World Bank Human Development Network, 2003 [online]. Available from URL: http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Resources/281627-1095698140167/Guindon-PastCurrent-whole.pdf [Accessed 2008 Jun18]

Download references

Acknowledgements

This work was supported by a Flight Attendant Medical Research Institute grant, an Annenberg Career Development Award and an American Histiocytosis Association award to Dr Robert Vassallo. The authors have no conflict of interest or any disclosures relevant to this publication. All authors have directly contributed to the content of this article and reviewed the final version.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Vassallo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Patel, R.R., Ryu, J.H. & Vassallo, R. Cigarette Smoking and Diffuse Lung Disease. Drugs 68, 1511–1527 (2008). https://doi.org/10.2165/00003495-200868110-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200868110-00004

Keywords

Navigation